Fabry disease trials in United States
8 of 13 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleMaternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
- Where
- Washington D.C.
- People
- 10 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT06941025 - No phaseTaking peopleA Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
- Where
- Philadelphia
- People
- 20
- Run by
- Amicus Therapeutics
See details and how to joinNCT04252066 - No phaseTaking peopleA Study of Patients With Fabry Disease (US Specific)
- Where
- Atlanta, Birmingham, Dallas, Fairfax, Little Rock, New York, Pittsburgh, St Louis
- Age
- 18 years and over
- People
- 450
- Run by
- Amicus Therapeutics
See details and how to joinNCT06906367 - No phaseTaking peopleFabry Disease Registry & Pregnancy Sub-registry
- Where
- Ann Arbor, Aurora, Baltimore, Baton Rouge, Birmingham, Boston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Coral Gables, Coral Springs, Dallas, Danville, Decatur, Detroit, Dublin, Durham, Fairfax, Fort Worth, Gainesville, Grand Rapids, Greenville, Hackensack, Helena, Hershey, Huntington, Indianapolis, Iowa City, Jacksonville, Kansas City, Las Vegas, Little Rock, Los Angeles, Louisville, Milwaukee, Minneapolis, Morristown, Nashville, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Omaha, Orange, Paterson, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Rochester, Sacramento, Salt Lake City, San Diego, San Francisco, Seattle, Springfield, Stanford, St Louis, Syracuse, Tacoma, Tampa, Tucson, Valhalla, Washington D.C.
- People
- 9,000 worldwide
- Run by
- Genzyme, a Sanofi Company
See details and how to joinNCT00196742 - No phaseTaking peopleNatural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease Study
- Where
- Minneapolis
- Age
- 1 year to 75 years
- People
- 50
- Run by
- University of Minnesota
See details and how to joinNCT01581424 - No phaseTaking peopleCardiovascular Multimodality Imaging Study
- Where
- The Bronx
- Age
- 18 years and over
- People
- 10,000
- Run by
- Montefiore Medical Center
See details and how to joinNCT06610019 - No phaseEnrolling by invitationScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program
- Where
- Brooklyn, Manhasset, New York, Queens, The Bronx
- Age
- Up to 4 weeks
- People
- 100,000
- Run by
- Albert Einstein College of Medicine
See details and how to joinNCT05368038 - No phaseTaking peopleA Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
- Where
- Atlanta, Birmingham, Chicago, Fairfax, Grand Rapids, Iowa City
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT06663358